Dean W. Felsher
Molecular Biology · 2002–2021
A researcher in the Science corpus: 8 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 84 citations into it; #13,867 of 17,773 by trust here, #9,727 by citations
- Oncology — 41 citations into it
- Cancer Research — 17 citations into it
- Hematology — 11 citations into it
Whom Dean W. Felsher trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Dean W. Felsher overall
Papers from Dean W. Felsher's perspective
Ordered by how strongly the researchers Dean W. Felsher trusts endorse each paper. Same corpus, a different order for every researcher.
- Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC (Science)
- Genomic targets of the human c-Myc protein. (Genes & Development)
- Repression of p15INK4b expression by Myc through association with Miz-1 (Nature Cell Biology)
- Transcriptional regulation and transformation by Myc proteins (Nature reviews. Molecular cell biology)
- Modelling Myc inhibition as a cancer therapy (Nature)
- c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism (Nature)
- The Myc/Max/Mad network and the transcriptional control of cell behavior. (Annual Review of Cell and Developmental Biology)
- The c-Myc target gene network. (Seminars in Cancer Biology)
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction (Proceedings of the National Academy of Sciences of the United States of America)
- c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. (Genes & Development)
Their papers
- MYC as a regulator of ribosome biogenesis and protein synthesis (2010) — 925 citations
- c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. (2006) — 931 citations
- The MYC oncogene — the grand orchestrator of cancer growth and immune evasion (2021) — 824 citations
- MYC Regulates the Anti-Tumor Immune Response through CD47 and PD-L1 (2016) — 1,260 citations
- NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis (2016) — 693 citations
- MYC activation is a hallmark of cancer initiation and maintenance. (2014) — 761 citations
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer (2004) — 898 citations
- Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC (2002) — 685 citations